Efficacy and Safety of Alogliptin Used in Combination With Sulfonylurea in Participants With Type 2 Diabetes in Japan
Status:
Completed
Trial end date:
2009-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study was evaluate the efficacy and safety of alogliptin, once daily (QD)
combined with an Sulfonylurea taken QD or twice daily (BID) in type 2 diabetic patients with
uncontrolled blood glucose.